|
1
|
Scholz J and Woolf CJ: The neuropathic
pain triad: Neurons, immune cells and glia. Nat Neurosci.
10:1361–1368. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Romero-Sandoval E Alfonso and Sweitzer S:
Nonneuronal central mechanisms of pain: Glia and immune response.
Prog Mol Biol Transl Sci. 131:325–358. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aloisi F: Immune function of microglia.
Glia. 36:165–179. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DeLeo JA and Yezierski RP: The role of
neuroinflammation and neuroimmune activation in persistent pain.
Pain. 90:1–6. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dong Y and Benveniste EN: Immune function
of astrocytes. Glia. 36:180–190. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mantyh PW, Clohisy DR, Koltzenburg M and
Hunt SP: Molecular mechanisms of cancer pain. Nat Rev Cancer.
2:201–209. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruohonen S, Jagodi M, Khademi M, Taskinen
HS, Ojala P, Olsson T and Röyttä M: Contralateral non-operated
nerve to transected rat sciatic nerve shows increased expression of
IL-1beta, TGF-beta1, TNF-alpha and IL-10. J Neuroimmunol.
132:11–17. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji RR, Berta T and Nedergaard M: Glia and
pain: Is chronic pain a gliopathy? Pain. 154:S10–28. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wolska A, Lech-Maranda E and Robak T:
Toll-like receptors and their role in hematologic malignancies.
Curr Mol Med. 9:324–335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Buchanan MM, Hutchinson M, Watkins LR and
Yin H: Toll-like receptor 4 in CNS pathologies. J Neurochem.
114:13–27. 2010.PubMed/NCBI
|
|
11
|
Park SW, Yi JH, Miranpuri G, Satriotomo I,
Bowen K, Resnick DK and Vemuganti R: Thiazolidinedione class of
peroxisome proliferator-activated receptor gamma agonists prevents
neuronal damage, motor dysfunction, myelin loss, neuropathic pain
and inflammation after spinal cord injury in adult rats. J
Pharmacol Exp Ther. 320:1002–1012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao Y, Patzer A, Herdegen T, Gohlke P and
Culman J: Activation of cerebral peroxisome proliferator-activated
receptors gamma promotes neuroprotection by attenuation of neuronal
cyclooxygenase-2 overexpression after focal cerebral ischemia in
rats. FASEB J. 20:1162–1175. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao X and Li LY: PPAR-alpha agonist
fenofibrate induces renal CYP enzymes and reduces blood pressure
and glomerular hypertrophy in Zucker diabetic fatty rats. Am J
Nephrol. 28:598–606. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Diab A, Hussain RZ, Lovett-Racke AE,
Chavis JA, Drew PD and Racke MK: Ligands for the peroxisome
proliferator-activated receptor-gamma and the retinoid X receptor
exert additive anti-inflammatory effects on experimental autoimmune
encephalomyelitis. J Neuroimmunol. 148:116–126. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Breidert T, Callebert J, Heneka MT,
Landreth G, Launay JM and Hirsch EC: Protective action of the
peroxisome proliferator-activated receptor-gamma agonist
pioglitazone in a mouse model of Parkinson's disease. J Neurochem.
82:615–624. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pedersen WA, McMillan PJ, Kulstad JJ,
Leverenz JB, Craft S and Haynatzki GR: Rosiglitazone attenuates
learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol.
199:265–273. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Heneka MT, Sastre M, Dumitrescu-Ozimek L,
Hanke A, Dewachter I, Kuiperi C, O'Banion K, Klockgether T, Van
Leuven F and Landreth GE: Acute treatment with the PPAR-gamma
agonist pioglitazone and ibuprofen reduces glial inflammation and
Abeta1-42 levels in APPV717I transgenic mice. Brain. 128:1442–1453.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bennett GJ and Xie YK: A peripheral
mononeuropathy in rat that produces disorders of pain sensation
like those seen in man. Pain. 33:87–107. 1998. View Article : Google Scholar
|
|
19
|
Chaplan SR, Bach FW, Pogrel JW, Chung JM
and Yaksh TL: Quantitative assessment of tactile allodynia in the
rat paw. J Neurosci Methods. 53:55–63. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim YI, Na HS, Yoon YW, Han HC, Ko KH and
Hong SK: NMDA receptors are important for both mechanical and
thermal allodynia from peripheral nerve injury in rats.
Neuroreport. 8:2149–2153. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jain V, Jaggi AS and Singh N: Ameliorative
potential of rosiglitazone in tibial and sural nerve
transection-induced painful neuropathy in rats. Pharmacol Res.
59:385–392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jia H, Zhu S, Ji Q, Hui K, Duan M, Xu J
and Li W: Repeated administration of pioglitazone attenuates
development of hyperalgesia in a rat model of neuropathic pain. Exp
Clin Psychopharmacol. 18:359–365. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maeda T, Kiguchi N, Kobayashi Y, Ozaki M
and Kishioka S: Pioglitazone attenuates tactile allodynia and
thermal hyperalgesia in mice subjected to peripheral nerve injury.
J Pharmacol Sci. 108:341–347. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takahashi Y, Hasegawa-Moriyama M, Sakurai
T and Inada E: The macrophage-mediated effects of the peroxisome
proliferator-activated receptor-gamma agonist rosiglitazone
attenuate tactile allodynia in the early phase of neuropathic pain
development. Anesth Analg. 113:398–404. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Churi SB, Abdel-Aleem OS, Tumber KK,
Scuderi-Porter H and Taylor BK: Intrathecal rosiglitazone acts at
peroxisome proliferator-activated receptor-gamma to rapidly inhibit
neuropathic pain in rats. J Pain. 9:639–649. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang ZJ, Cao DL, Zhang X, Ji RR and Gao
YJ: Chemokine contribution to neuropathic pain: Respective
induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons.
Pain. 154:2185–2197. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akimoto N, Ifuku M, Mori Y and Noda M:
Effects of chemokine (C-C motif) ligand 1 on microglial function.
Biochem Biophys Res Commun. 436:455–461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Clark AK, Old EA and Malcangio M:
Neuropathic pain and cytokines: Current perspectives. J Pain Res.
6:803–814. 2013.PubMed/NCBI
|
|
29
|
Ji RR and Suter MR: P38 MAPK, microglial
signaling, and neuropathic pain. Mol Pain. 3:332007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moalem G and Tracey DJ: Immune and
inflammatory mechanisms in neuropathic pain. Brain Res Rev.
51:240–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Inoue M, Yamada T and Ueda H: Low dose of
kyotorphin (tyrosine-arginine) induces nociceptive responses
through a substance P release from nociceptor endings. Brain Res
Mol Brain Res. 69:302–305. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zingarelli B, Sheehan M, Hake PW, O'Connor
M, Denenberg A and Cook JA: Peroxisome proliferator activator
receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and
ciglitazone, reduce systemic inflammation in polymicrobial sepsis
by modulation of signal transduction pathways. J Immunol.
171:6827–6837. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fuenzalida K, Quintanilla R, Ramos P,
Piderit D, Fuentealba RA, Martinez G, Inestrosa NC and Bronfman M:
Peroxisome proliferator-activated receptor gamma up-regulates the
Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial
stabilization and protection against oxidative stress and
apoptosis. J Biol Chem. 282:37006–37015. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bernardo A, Ajmone-Cat MA, Gasparini L,
Ongini E and Minghetti L: Nuclear receptor peroxisome
proliferator-activated receptor-gamma is activated in rat
microglial cells by the anti-inflammatory drug HCT1026, a
derivative of flurbiprofen. J Neurochem. 92:895–903. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Watkins LR, Milligan ED and Maier SF:
Glial activation: A driving force for pathological pain. Trends
Neurosci. 24:450–455. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luna-Medina R, Cortes-Canteli M, Alonso M,
Santos A, Martínez A and Perez-Castillo A: Regulation of
inflammatory response in neural cells in vitro by
thiadiazolidinones derivatives through peroxisome
proliferator-activated receptor gamma activation. J Biol Chem.
280:21453–21462. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen Y, Willcockson HH and Valtschanoff
JG: Influence of the vanilloid receptor TRPV1 on the activation of
spinal cord glia in mouse models of pain. Exp Neurol. 220:383–390.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moreno S, Farioli-Vecchioli S and Cerù MP:
Immunolocalization of peroxisome proliferator-activated receptors
and retinoid X receptors in the adult rat CNS. Neuroscience.
123:131–145. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Diab A, Deng C, Smith JD, Hussain RZ,
Phanavanh B, Lovett-Racke AE, Drew PD and Racke MK: Peroxisome
proliferator-activated receptor-gamma agonist 15-deoxy-Delta
(12,14)-prostaglandin J2 ameliorates experimental autoimmune
encephalomyelitis. J Immunol. 168:2508–2515. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hutchinson MR, Zhang Y, Brown K, Coats BD,
Shridhar M, Sholar PW, Patel SJ, Crysdale NY, Harrison JA, Maier
SF, et al: Non-stereoselective reversal of neuropathic pain by
naloxone and naltrexone: Involvement of toll-like receptor 4
(TLR4). Eur J Neurosci. 28:20–29. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cao L, Tanga FY and DeLeo JA: The
contributing role of CD14 in toll-like receptor 4 dependent
neuropathic pain. Neuroscience. 158:896–903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Miyake K: Innate immune sensing of
pathogens and danger signals by cell surface Toll-like receptors.
Semin Immunol. 19:3–10. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gurley C, Nichols J, Liu S, Phulwani NK,
Esen N and Kielian T: Microglia and Astrocyte Activation by
Toll-Like Receptor Ligands: Modulation by PPAR-gamma Agonists. PPAR
Res. 2008:4531202008. View Article : Google Scholar : PubMed/NCBI
|
